Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-02 Sale |
2022-02-03 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,660 | $251.47 | $1,171,842 | 65,697 (Direct) |
View |
| 2022-01-28 Sale |
2022-02-01 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $241.79 | $1,208,960 | 16,099 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
51 | $187.19 | $9,547 | 48,383 (Indirect Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3 | $187.26 | $562 | 41,243 (Indirect Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
34 | $187.22 | $6,365 | 33,589 (Direct) |
View |
| 2021-08-19 Purchase |
2021-08-23 08:30 am |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
10,000 | $195.65 | $1,956,492 | 73,754 (Direct) |
View |
| 2021-08-02 Purchase |
2021-08-04 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
15,000 | $197.91 | $2,968,650 | 41,210 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-04 4:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
559 | $209.69 | $117,216 | 5,191 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
699 | $0 | $0 | 5,787 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
112 | $216.34 | $24,230 | 34,108 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
45 | $216.35 | $9,736 | 48,383 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
112 | $216.34 | $24,230 | 8,253 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Comm & Ops Officer |
109 | $216.41 | $23,589 | 41,243 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
79 | $216.36 | $17,093 | 33,589 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 9:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
960 | $218.43 | $209,691 | 34,108 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-01 Option Award |
2022-02-03 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
29,638 | $0 | 78,021 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
8,941 | $0 | 17,194 (Direct) |
View |
| 2022-02-02 Tax Withholding |
2022-02-03 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
6,279 | $243.63 | 110,766 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
66,817 | $0 | 110,766 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
67,949 | $0 | 141,703 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
23,988 | $0 | 56,941 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
38,375 | $0 | 79,618 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
2,566 | $0 | 3,960 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-03 4:06 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,660 | $86.52 | 65,697 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,108 | $0 | 65,697 (Direct) |
View |
| 2022-01-28 Exercise |
2022-02-01 4:09 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $127.54 | 16,099 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
190 | $230.58 | 13,672 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
119 | $230.58 | 794 (Direct) |
View |
| 2021-11-01 Tax Withholding |
2021-11-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $185.07 | 32,576 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
240 | $182.07 | 13,483 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
151 | $182.07 | 674 (Direct) |
View |
| 2021-07-30 Tax Withholding |
2021-08-03 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $200.39 | 33,342 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
221 | $198 | 13,242 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
139 | $198 | 523 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
699 | $0 | 5,787 (Direct) |
View |
| 2021-05-28 Tax Withholding |
2021-06-02 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
311 | $210.04 | 32,953 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-05 9:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
547 | $217.21 | 34,679 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-05 9:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $217.21 | 34,108 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:20 pm |
N/A 2031-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
6,067 | $0 | 6,067 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
1,842 | $0 | 3,484 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:17 pm |
N/A 2031-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
3,955 | $0 | 4,832 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:13 pm |
N/A 2031-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
6,067 | $0 | 6,067 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:12 pm |
N/A 2031-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
6,067 | $0 | 6,067 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:08 pm |
N/A 2031-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director |
6,067 | $0 | 6,067 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
1,842 | $0 | 5,401 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,842 | $0 | 5,750 (Direct) |
View |